Skip to main content
Caplight Logo









Axinesis

Axinesis

Private
WavreHealthcare & Life Scienceshttps://www.axinesis.com/en/

Last Round

M&A

Mar 10, 2026

Total Funding Raised

$1.93M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Axinesis is a medical technology company that develops robotic devices for upper limb neurorehabilitation to assist patients with motor and cognitive disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Industrial Robotics, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neurorehabilitationrehabilitation roboticsmedical devicesupper-limb rehabilitationrehab roboticstherapeutic gamificationstroke recoveryneuroplasticityphysical therapyphysio techmedical hardwaremovement therapyrehab techmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Axinesis Comparables

Compare Axinesis with similar companies based on industry and business-model similarity.

Axinesis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tyromotion
84%
Bionik Laboratories Corp.
81%
DIH Medical
80%

Axinesis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AMar 10, 2026

Key People

Founding team and executive leadership

Julien Sapin

CEO

Executive Team

Axinesis Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 99% MoM, reaching 1.7K.

  • May 15, 2026

    Monthly visitors increased 61% MoM, reaching 2.6K.

Axinesis Filings

Explore SEC and related filing metadata, where available.

Axinesis filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Axinesis's valuation, stock price, and market status.

Is Axinesis a public or private company?

Axinesis is a private company.

What is the current stock price of Axinesis?

Axinesis is a private company with no public stock price. No recent secondary market data is available.

How much is Axinesis worth (valuation)?

Valuation information for Axinesis is not publicly available.

Can I buy Axinesis stock?

Axinesis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Axinesis's last funding round?

Axinesis's most recent funding round was M&A on March 10, 2026.

Who are the main investors in Axinesis?

Key investors in Axinesis include Walloon Region (Belgium).

Will Axinesis IPO soon?

No public IPO plans have been announced for Axinesis.

How can I track Axinesis secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Axinesis's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWavre
Employee Range7
Year Founded2015
Last FundingMar 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?